Erlenbach, Switzerland

Christoph Hock

USPTO Granted Patents = 20 

 

 

Average Co-Inventor Count = 6.0

ph-index = 8

Forward Citations = 147(Granted Patents)


Company Filing History:


Years Active: 2003-2022

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Christoph Hock: Innovator in Neuroscience with 20 Patents

Introduction

Christoph Hock, based in Erlenbach, Switzerland, has made significant contributions to the field of neuroscience through his innovative research and patented inventions. With a total of 20 patents to his name, his work predominantly focuses on therapeutic approaches targeting neurodegenerative diseases.

Latest Patents

One of Hock's latest patents is for **Human anti-SOD1 antibodies**. This innovation features novel human copper-zinc superoxide dismutase, also known as superoxide dismutase 1 (SOD1), specific antibodies along with their fragments, derivatives, and variants. The patent also includes methods related to these antibodies, as well as assays, kits, and solid supports intended for SOD1-targeted immunotherapy and diagnostic applications.

Another notable patent is for **TDP-43 specific binding molecules**. This invention encompasses TAR DNA-binding protein of 43 kDa (TDP-43)-specific binding molecules, which include polypeptides such as human antibodies and their derivatives. The patent further describes methods associated with these binding molecules, including assays and solid supports relevant to TDP-43-targeted immunotherapy and diagnosis.

Career Highlights

Hock has gained valuable experience while working with reputable institutions such as the University of Zürich and Biogen International Neuroscience GmbH. His research has led to significant advancements in the understanding of neurodegenerative diseases and potential treatments.

Collaborations

Throughout his career, Christoph Hock has collaborated with other esteemed researchers in the field, including Roger Nitsch and Jan Grimm. These collaborations have helped to enhance the depth and impact of his research contributions.

Conclusion

Christoph Hock exemplifies the spirit of innovation in the realm of neuroscience. His impressive portfolio of patents and collaboration with leading institutions and researchers underscore his commitment to developing novel therapeutic strategies for addressing critical health challenges associated with neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…